Professor Sarah Tabrizi talks to Dr Aisah Aubdool about her keynote session at WCP2023

Register now:
https://www.wcp2023.org/register

View the WCP2023 programme:
https://www.wcp2023.org/programme

View activities and resources for Early Career Researchers (ECRs):
https://www.wcp2023.org/early-career-...

---

Professor Sarah Tabrizi talks to Dr Aisah Abdool about her keynote session at the 19th World Congress of Basic and Clinical Pharmacology (WCP2023): 'Gene targeting therapies for Huntington’s disease: What does the future hold for neurodegenerative disorders?'  |  6 July 2023  |  8:30 am - 9:20 am

---

Professor Sarah Tabrizi is Director of the UCL Huntington’s Disease (HD) Centre, Joint Head of Department Neurodegenerative Disease at the UCL Queen Square Institute of Neurology, a Principal Investigator at the UK Dementia Research Institute, and Consultant Neurologist at the National Hospital for Neurology and Neurosurgery.

Dr Aisah Aubdool is a Lecturer in Cardiovascular Pharmacology at the William Harvey Research Institute, Queen Mary University of London, a Regional Ambassador Coordinator for the British Pharmacological Society, and a Member of the Pharmacological Matters Editorial Board.